nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—CYP1A1—kidney cancer	0.611	1	CbGaD
Clobetasol propionate—CYP1A1—Erlotinib—kidney cancer	0.081	0.411	CbGbCtD
Clobetasol propionate—CYP1A2—Pazopanib—kidney cancer	0.0507	0.257	CbGbCtD
Clobetasol propionate—CYP1A2—Erlotinib—kidney cancer	0.0362	0.183	CbGbCtD
Clobetasol propionate—CYP1A2—Sorafenib—kidney cancer	0.0294	0.149	CbGbCtD
Clobetasol propionate—Pustule—Erlotinib—kidney cancer	0.00952	0.0633	CcSEcCtD
Clobetasol propionate—Rosacea—Erlotinib—kidney cancer	0.0059	0.0392	CcSEcCtD
Clobetasol propionate—Leukoderma—Pazopanib—kidney cancer	0.00398	0.0264	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Everolimus—kidney cancer	0.00391	0.026	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Erlotinib—kidney cancer	0.00377	0.0251	CcSEcCtD
Clobetasol propionate—Hypertrichosis—Everolimus—kidney cancer	0.00351	0.0233	CcSEcCtD
Clobetasol propionate—Folliculitis—Temsirolimus—kidney cancer	0.00286	0.019	CcSEcCtD
Clobetasol propionate—Rosacea—Capecitabine—kidney cancer	0.00282	0.0187	CcSEcCtD
Clobetasol propionate—Leukoderma—Sunitinib—kidney cancer	0.00262	0.0174	CcSEcCtD
Clobetasol propionate—Rash pustular—Temsirolimus—kidney cancer	0.00225	0.015	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Erlotinib—kidney cancer	0.00217	0.0144	CcSEcCtD
Clobetasol propionate—Folliculitis—Everolimus—kidney cancer	0.00212	0.0141	CcSEcCtD
Clobetasol propionate—Folliculitis—Erlotinib—kidney cancer	0.00205	0.0136	CcSEcCtD
Clobetasol propionate—Amcinonide—ANXA1—kidney cancer	0.00195	0.453	CrCbGaD
Clobetasol propionate—Skin hyperpigmentation—Sunitinib—kidney cancer	0.00187	0.0125	CcSEcCtD
Clobetasol propionate—Folliculitis—Sorafenib—kidney cancer	0.00184	0.0123	CcSEcCtD
Clobetasol propionate—CYP1A2—urine—kidney cancer	0.00178	0.235	CbGeAlD
Clobetasol propionate—Eruption—Dactinomycin—kidney cancer	0.00172	0.0114	CcSEcCtD
Clobetasol propionate—NR3C1—urine—kidney cancer	0.0017	0.225	CbGeAlD
Clobetasol propionate—Folliculitis—Dactinomycin—kidney cancer	0.00168	0.0112	CcSEcCtD
Clobetasol propionate—Rash pustular—Erlotinib—kidney cancer	0.00162	0.0107	CcSEcCtD
Clobetasol propionate—Tenderness—Erlotinib—kidney cancer	0.00148	0.00981	CcSEcCtD
Clobetasol propionate—Eruption—Gemcitabine—kidney cancer	0.00145	0.00967	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—kidney cancer	0.00135	0.00896	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Paclitaxel—kidney cancer	0.00126	0.00837	CcSEcCtD
Clobetasol propionate—Dry skin—Temsirolimus—kidney cancer	0.00119	0.00794	CcSEcCtD
Clobetasol propionate—Folliculitis—Paclitaxel—kidney cancer	0.00119	0.00792	CcSEcCtD
Clobetasol propionate—Dry skin—Pazopanib—kidney cancer	0.00112	0.00748	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Capecitabine—kidney cancer	0.00103	0.00687	CcSEcCtD
Clobetasol propionate—Tenderness—Gemcitabine—kidney cancer	0.00103	0.00682	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Temsirolimus—kidney cancer	0.00102	0.00675	CcSEcCtD
Clobetasol propionate—Pain in extremity—Everolimus—kidney cancer	0.000969	0.00644	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—kidney cancer	0.000932	0.0062	CcSEcCtD
Clobetasol propionate—Tingling sensation—Paclitaxel—kidney cancer	0.000932	0.00619	CcSEcCtD
Clobetasol propionate—Dry skin—Everolimus—kidney cancer	0.000888	0.0059	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Temsirolimus—kidney cancer	0.000888	0.0059	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Temsirolimus—kidney cancer	0.000886	0.00589	CcSEcCtD
Clobetasol propionate—Eye irritation—Paclitaxel—kidney cancer	0.000877	0.00583	CcSEcCtD
Clobetasol propionate—Tenderness—Paclitaxel—kidney cancer	0.000859	0.00571	CcSEcCtD
Clobetasol propionate—Dry skin—Erlotinib—kidney cancer	0.000857	0.0057	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Pazopanib—kidney cancer	0.000845	0.00562	CcSEcCtD
Clobetasol propionate—Pain in extremity—Sorafenib—kidney cancer	0.000841	0.00559	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Pazopanib—kidney cancer	0.000836	0.00556	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Pazopanib—kidney cancer	0.000834	0.00555	CcSEcCtD
Clobetasol propionate—Pain in extremity—Sunitinib—kidney cancer	0.000809	0.00538	CcSEcCtD
Clobetasol propionate—Erythema—Temsirolimus—kidney cancer	0.000785	0.00522	CcSEcCtD
Clobetasol propionate—Dry skin—Sorafenib—kidney cancer	0.000771	0.00513	CcSEcCtD
Clobetasol propionate—Tingling sensation—Capecitabine—kidney cancer	0.000765	0.00508	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Everolimus—kidney cancer	0.000755	0.00502	CcSEcCtD
Clobetasol propionate—Alopecia—Pazopanib—kidney cancer	0.00075	0.00499	CcSEcCtD
Clobetasol propionate—Dry skin—Sunitinib—kidney cancer	0.000742	0.00493	CcSEcCtD
Clobetasol propionate—Erythema—Pazopanib—kidney cancer	0.000739	0.00491	CcSEcCtD
Clobetasol propionate—Eye irritation—Capecitabine—kidney cancer	0.00072	0.00479	CcSEcCtD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.000702	0.0239	CbGpPWpGaD
Clobetasol propionate—Pain in extremity—Vincristine—kidney cancer	0.000685	0.00455	CcSEcCtD
Clobetasol propionate—CYP1A2—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000677	0.0231	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—FOSL2—kidney cancer	0.00067	0.0228	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Vinblastine—kidney cancer	0.00067	0.00445	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Everolimus—kidney cancer	0.000667	0.00443	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—kidney cancer	0.000666	0.00443	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.000663	0.00441	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Everolimus—kidney cancer	0.00066	0.00439	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Everolimus—kidney cancer	0.000659	0.00438	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—kidney cancer	0.000644	0.00428	CcSEcCtD
Clobetasol propionate—Infection—Temsirolimus—kidney cancer	0.000636	0.00423	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Erlotinib—kidney cancer	0.000636	0.00423	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Sunitinib—kidney cancer	0.000631	0.0042	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—kidney cancer	0.00063	0.00419	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—kidney cancer	0.00063	0.00419	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.000625	0.00415	CcSEcCtD
Clobetasol propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—kidney cancer	0.000624	0.0213	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Temsirolimus—kidney cancer	0.000622	0.00413	CcSEcCtD
Clobetasol propionate—Dexamethasone—ANXA1—kidney cancer	0.000611	0.142	CrCbGaD
Clobetasol propionate—Infection—Pazopanib—kidney cancer	0.000599	0.00398	CcSEcCtD
Clobetasol propionate—Alopecia—Vinblastine—kidney cancer	0.000595	0.00395	CcSEcCtD
Clobetasol propionate—Alopecia—Everolimus—kidney cancer	0.000592	0.00394	CcSEcCtD
Clobetasol propionate—Skin disorder—Pazopanib—kidney cancer	0.000586	0.00389	CcSEcCtD
Clobetasol propionate—Erythema—Everolimus—kidney cancer	0.000584	0.00388	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Sorafenib—kidney cancer	0.000572	0.0038	CcSEcCtD
Clobetasol propionate—Alopecia—Erlotinib—kidney cancer	0.000572	0.0038	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.000569	0.0194	CbGpPWpGaD
Clobetasol propionate—Erythema—Erlotinib—kidney cancer	0.000563	0.00374	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Sunitinib—kidney cancer	0.000557	0.0037	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Sunitinib—kidney cancer	0.000552	0.00367	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Sunitinib—kidney cancer	0.00055	0.00366	CcSEcCtD
Clobetasol propionate—NR3C1—Endoderm Differentiation—CER1—kidney cancer	0.000548	0.0187	CbGpPWpGaD
Clobetasol propionate—Pain—Temsirolimus—kidney cancer	0.000548	0.00364	CcSEcCtD
Clobetasol propionate—Pain in extremity—Paclitaxel—kidney cancer	0.000544	0.00361	CcSEcCtD
Clobetasol propionate—Paraesthesia—Pazopanib—kidney cancer	0.000542	0.0036	CcSEcCtD
Clobetasol propionate—Pain—Pazopanib—kidney cancer	0.000516	0.00343	CcSEcCtD
Clobetasol propionate—Alopecia—Sorafenib—kidney cancer	0.000514	0.00342	CcSEcCtD
Clobetasol propionate—Erythema—Sorafenib—kidney cancer	0.000507	0.00337	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Gemcitabine—kidney cancer	0.000506	0.00337	CcSEcCtD
Clobetasol propionate—Vascular purpura—Capecitabine—kidney cancer	0.000499	0.00332	CcSEcCtD
Clobetasol propionate—Dry skin—Paclitaxel—kidney cancer	0.000498	0.00331	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—kidney cancer	0.000497	0.0033	CcSEcCtD
Clobetasol propionate—Alopecia—Sunitinib—kidney cancer	0.000495	0.00329	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000493	0.00328	CcSEcCtD
Clobetasol propionate—CYP1A2—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000491	0.0167	CbGpPWpGaD
Clobetasol propionate—Stinging—Doxorubicin—kidney cancer	0.000489	0.00325	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—kidney cancer	0.000489	0.00325	CcSEcCtD
Clobetasol propionate—Erythema—Sunitinib—kidney cancer	0.000487	0.00324	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000476	0.00316	CcSEcCtD
Clobetasol propionate—Infection—Everolimus—kidney cancer	0.000473	0.00315	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Temsirolimus—kidney cancer	0.000472	0.00314	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Vincristine—kidney cancer	0.000471	0.00313	CcSEcCtD
Clobetasol propionate—Alopecia—Dactinomycin—kidney cancer	0.000468	0.00311	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Vincristine—kidney cancer	0.000465	0.00309	CcSEcCtD
Clobetasol propionate—Purpura—Capecitabine—kidney cancer	0.000463	0.00308	CcSEcCtD
Clobetasol propionate—Skin disorder—Everolimus—kidney cancer	0.000463	0.00308	CcSEcCtD
Clobetasol propionate—Erythema—Dactinomycin—kidney cancer	0.000461	0.00307	CcSEcCtD
Clobetasol propionate—NR3C1—nephron tubule—kidney cancer	0.000458	0.0606	CbGeAlD
Clobetasol propionate—Infection—Erlotinib—kidney cancer	0.000457	0.00303	CcSEcCtD
Clobetasol propionate—CYP1A1—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000456	0.0155	CbGpPWpGaD
Clobetasol propionate—Pruritus—Temsirolimus—kidney cancer	0.000453	0.00301	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—FOSL1—kidney cancer	0.000447	0.0152	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Erlotinib—kidney cancer	0.000446	0.00297	CcSEcCtD
Clobetasol propionate—Pain in extremity—Capecitabine—kidney cancer	0.000446	0.00297	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Gemcitabine—kidney cancer	0.000443	0.00294	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Gemcitabine—kidney cancer	0.000442	0.00294	CcSEcCtD
Clobetasol propionate—CYP1A2—renal system—kidney cancer	0.000435	0.0575	CbGeAlD
Clobetasol propionate—Paraesthesia—Vinblastine—kidney cancer	0.000429	0.00285	CcSEcCtD
Clobetasol propionate—CYP1A1—renal system—kidney cancer	0.000429	0.0568	CbGeAlD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000428	0.00285	CcSEcCtD
Clobetasol propionate—Paraesthesia—Everolimus—kidney cancer	0.000428	0.00284	CcSEcCtD
Clobetasol propionate—Pruritus—Pazopanib—kidney cancer	0.000427	0.00284	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Paclitaxel—kidney cancer	0.000424	0.00282	CcSEcCtD
Clobetasol propionate—Alopecia—Vincristine—kidney cancer	0.000419	0.00278	CcSEcCtD
Clobetasol propionate—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.000418	0.0142	CbGpPWpGaD
Clobetasol propionate—NR3C1—renal system—kidney cancer	0.000416	0.0551	CbGeAlD
Clobetasol propionate—CYP1A1—kidney—kidney cancer	0.000414	0.0549	CbGeAlD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000412	0.00274	CcSEcCtD
Clobetasol propionate—Infection—Sorafenib—kidney cancer	0.000411	0.00273	CcSEcCtD
Clobetasol propionate—Dry skin—Capecitabine—kidney cancer	0.000409	0.00272	CcSEcCtD
Clobetasol propionate—Pain—Vinblastine—kidney cancer	0.000409	0.00272	CcSEcCtD
Clobetasol propionate—Pain—Everolimus—kidney cancer	0.000407	0.00271	CcSEcCtD
Clobetasol propionate—NR3C1—Endoderm Differentiation—BMP7—kidney cancer	0.000404	0.0138	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—HNF1B—kidney cancer	0.000404	0.0138	CbGpPWpGaD
Clobetasol propionate—Rash—Temsirolimus—kidney cancer	0.000404	0.00268	CcSEcCtD
Clobetasol propionate—Dermatitis—Temsirolimus—kidney cancer	0.000403	0.00268	CcSEcCtD
Clobetasol propionate—NR3C1—kidney—kidney cancer	0.000402	0.0532	CbGeAlD
Clobetasol propionate—Skin disorder—Sorafenib—kidney cancer	0.000402	0.00267	CcSEcCtD
Clobetasol propionate—Headache—Temsirolimus—kidney cancer	0.000401	0.00267	CcSEcCtD
Clobetasol propionate—Alopecia—Gemcitabine—kidney cancer	0.000397	0.00264	CcSEcCtD
Clobetasol propionate—Infection—Sunitinib—kidney cancer	0.000395	0.00263	CcSEcCtD
Clobetasol propionate—Pain—Erlotinib—kidney cancer	0.000393	0.00261	CcSEcCtD
Clobetasol propionate—NR3C1—cortex of kidney—kidney cancer	0.000392	0.0519	CbGeAlD
Clobetasol propionate—Dermatitis contact—Doxorubicin—kidney cancer	0.000392	0.0026	CcSEcCtD
Clobetasol propionate—Erythema—Gemcitabine—kidney cancer	0.000391	0.0026	CcSEcCtD
Clobetasol propionate—CYP1A1—Melatonin metabolism and effects—ACHE—kidney cancer	0.000388	0.0132	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Sunitinib—kidney cancer	0.000386	0.00257	CcSEcCtD
Clobetasol propionate—CYP1A1—cardiac atrium—kidney cancer	0.000384	0.0508	CbGeAlD
Clobetasol propionate—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.00038	0.013	CbGpPWpGaD
Clobetasol propionate—Rash—Pazopanib—kidney cancer	0.00038	0.00253	CcSEcCtD
Clobetasol propionate—Dermatitis—Pazopanib—kidney cancer	0.00038	0.00253	CcSEcCtD
Clobetasol propionate—Headache—Pazopanib—kidney cancer	0.000378	0.00251	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Paclitaxel—kidney cancer	0.000374	0.00249	CcSEcCtD
Clobetasol propionate—Triamcinolone—BCHE—kidney cancer	0.000374	0.0871	CrCbGaD
Clobetasol propionate—Infection—Dactinomycin—kidney cancer	0.000374	0.00249	CcSEcCtD
Clobetasol propionate—NR3C1—gonad—kidney cancer	0.000373	0.0494	CbGeAlD
Clobetasol propionate—NR3C1—cardiac atrium—kidney cancer	0.000373	0.0493	CbGeAlD
Clobetasol propionate—Oedema peripheral—Paclitaxel—kidney cancer	0.000371	0.00246	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Paclitaxel—kidney cancer	0.00037	0.00246	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen metabolism—GSTM1—kidney cancer	0.000362	0.0123	CbGpPWpGaD
Clobetasol propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	0.000359	0.0122	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Sunitinib—kidney cancer	0.000357	0.00237	CcSEcCtD
Clobetasol propionate—Pain—Sorafenib—kidney cancer	0.000354	0.00235	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vinblastine—kidney cancer	0.000352	0.00234	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Everolimus—kidney cancer	0.000351	0.00233	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Capecitabine—kidney cancer	0.000348	0.00231	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	0.000345	0.0118	CbGpPWpGaD
Clobetasol propionate—Pain—Sunitinib—kidney cancer	0.00034	0.00226	CcSEcCtD
Clobetasol propionate—Pruritus—Everolimus—kidney cancer	0.000337	0.00224	CcSEcCtD
Clobetasol propionate—Infection—Vincristine—kidney cancer	0.000334	0.00222	CcSEcCtD
Clobetasol propionate—Alopecia—Paclitaxel—kidney cancer	0.000332	0.00221	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000331	0.0022	CcSEcCtD
Clobetasol propionate—Erythema—Paclitaxel—kidney cancer	0.000327	0.00218	CcSEcCtD
Clobetasol propionate—Pruritus—Erlotinib—kidney cancer	0.000325	0.00216	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUND—kidney cancer	0.000325	0.0111	CbGpPWpGaD
Clobetasol propionate—Pain—Dactinomycin—kidney cancer	0.000322	0.00214	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—kidney cancer	0.000322	0.00214	CcSEcCtD
Clobetasol propionate—Infection—Gemcitabine—kidney cancer	0.000317	0.00211	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—JUNB—kidney cancer	0.000311	0.0106	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Gemcitabine—kidney cancer	0.00031	0.00206	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Capecitabine—kidney cancer	0.000307	0.00204	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Sorafenib—kidney cancer	0.000305	0.00202	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Capecitabine—kidney cancer	0.000304	0.00202	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Capecitabine—kidney cancer	0.000303	0.00202	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vincristine—kidney cancer	0.000302	0.00201	CcSEcCtD
Clobetasol propionate—Rash—Everolimus—kidney cancer	0.0003	0.002	CcSEcCtD
Clobetasol propionate—Dermatitis—Everolimus—kidney cancer	0.0003	0.00199	CcSEcCtD
Clobetasol propionate—Headache—Vinblastine—kidney cancer	0.0003	0.00199	CcSEcCtD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000299	0.0102	CbGpPWpGaD
Clobetasol propionate—Purpura—Doxorubicin—kidney cancer	0.000298	0.00198	CcSEcCtD
Clobetasol propionate—Headache—Everolimus—kidney cancer	0.000298	0.00198	CcSEcCtD
Clobetasol propionate—NR3C1—Adipogenesis—HNF1A—kidney cancer	0.000295	0.0101	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—EPAS1—kidney cancer	0.000295	0.0101	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Sunitinib—kidney cancer	0.000293	0.00195	CcSEcCtD
Clobetasol propionate—Pruritus—Sorafenib—kidney cancer	0.000292	0.00194	CcSEcCtD
Clobetasol propionate—CYP1A2—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000291	0.00991	CbGpPWpGaD
Clobetasol propionate—Rash—Erlotinib—kidney cancer	0.00029	0.00193	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—ACY1—kidney cancer	0.00029	0.00987	CbGpPWpGaD
Clobetasol propionate—Dermatitis—Erlotinib—kidney cancer	0.000289	0.00192	CcSEcCtD
Clobetasol propionate—Headache—Erlotinib—kidney cancer	0.000288	0.00191	CcSEcCtD
Clobetasol propionate—Pain—Vincristine—kidney cancer	0.000288	0.00191	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—kidney cancer	0.000288	0.00191	CcSEcCtD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—GLIPR1—kidney cancer	0.000287	0.00979	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Gemcitabine—kidney cancer	0.000287	0.00191	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—CYP1A1—kidney cancer	0.000284	0.00966	CbGpPWpGaD
Clobetasol propionate—Pruritus—Sunitinib—kidney cancer	0.000281	0.00187	CcSEcCtD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—GLIPR1—kidney cancer	0.000281	0.00958	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Dactinomycin—kidney cancer	0.000277	0.00184	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000277	0.00184	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.000274	0.00935	CbGpPWpGaD
Clobetasol propionate—Pain—Gemcitabine—kidney cancer	0.000273	0.00181	CcSEcCtD
Clobetasol propionate—Alopecia—Capecitabine—kidney cancer	0.000273	0.00181	CcSEcCtD
Clobetasol propionate—Erythema—Capecitabine—kidney cancer	0.000269	0.00179	CcSEcCtD
Clobetasol propionate—Infection—Paclitaxel—kidney cancer	0.000266	0.00176	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—kidney cancer	0.000264	0.00175	CcSEcCtD
Clobetasol propionate—Rash—Sorafenib—kidney cancer	0.000261	0.00173	CcSEcCtD
Clobetasol propionate—Dermatitis—Sorafenib—kidney cancer	0.00026	0.00173	CcSEcCtD
Clobetasol propionate—Skin disorder—Paclitaxel—kidney cancer	0.00026	0.00173	CcSEcCtD
Clobetasol propionate—Headache—Sorafenib—kidney cancer	0.000259	0.00172	CcSEcCtD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	0.000255	0.00871	CbGpPWpGaD
Clobetasol propionate—Rash—Sunitinib—kidney cancer	0.000251	0.00167	CcSEcCtD
Clobetasol propionate—Dermatitis—Sunitinib—kidney cancer	0.000251	0.00167	CcSEcCtD
Clobetasol propionate—Headache—Sunitinib—kidney cancer	0.000249	0.00166	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vincristine—kidney cancer	0.000248	0.00165	CcSEcCtD
Clobetasol propionate—CYP1A2—Melatonin metabolism and effects—ACHE—kidney cancer	0.000247	0.00842	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Oxidative Stress—SOD2—kidney cancer	0.000241	0.00822	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.00024	0.00818	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Paclitaxel—kidney cancer	0.00024	0.0016	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen Receptor Pathway—JUN—kidney cancer	0.000238	0.00813	CbGpPWpGaD
Clobetasol propionate—Rash—Dactinomycin—kidney cancer	0.000237	0.00158	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	0.000235	0.008	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000235	0.008	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Estrogen metabolism—GSTM1—kidney cancer	0.000231	0.00786	CbGpPWpGaD
Clobetasol propionate—Pain—Paclitaxel—kidney cancer	0.000229	0.00152	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000227	0.00151	CcSEcCtD
Clobetasol propionate—Pruritus—Gemcitabine—kidney cancer	0.000226	0.0015	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—kidney cancer	0.000224	0.00149	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000221	0.00753	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	0.00022	0.00749	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Estrogen metabolism—CYP1A1—kidney cancer	0.000219	0.00745	CbGpPWpGaD
Clobetasol propionate—Fluticasone furoate—ABCB1—kidney cancer	0.000218	0.0508	CrCbGaD
Clobetasol propionate—Infection—Capecitabine—kidney cancer	0.000218	0.00145	CcSEcCtD
Clobetasol propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	0.000216	0.00737	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Capecitabine—kidney cancer	0.000213	0.00142	CcSEcCtD
Clobetasol propionate—Rash—Vincristine—kidney cancer	0.000212	0.00141	CcSEcCtD
Clobetasol propionate—Dermatitis—Vincristine—kidney cancer	0.000212	0.00141	CcSEcCtD
Clobetasol propionate—Headache—Vincristine—kidney cancer	0.000211	0.0014	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—kidney cancer	0.000207	0.00706	CbGpPWpGaD
Clobetasol propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	0.000206	0.00701	CbGpPWpGaD
Clobetasol propionate—Rash—Gemcitabine—kidney cancer	0.000201	0.00134	CcSEcCtD
Clobetasol propionate—Dermatitis—Gemcitabine—kidney cancer	0.000201	0.00134	CcSEcCtD
Clobetasol propionate—CYP1A2—Xenobiotics—CYP1A1—kidney cancer	0.000201	0.00685	CbGpPWpGaD
Clobetasol propionate—Headache—Gemcitabine—kidney cancer	0.0002	0.00133	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—kidney cancer	0.000198	0.00132	CcSEcCtD
Clobetasol propionate—Paraesthesia—Capecitabine—kidney cancer	0.000197	0.00131	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Paclitaxel—kidney cancer	0.000197	0.00131	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—kidney cancer	0.000196	0.0013	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—kidney cancer	0.000196	0.0013	CcSEcCtD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—GLIPR1—kidney cancer	0.000194	0.0066	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	0.000194	0.0066	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000193	0.00658	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000191	0.00649	CbGpPWpGaD
Clobetasol propionate—Pruritus—Paclitaxel—kidney cancer	0.000189	0.00126	CcSEcCtD
Clobetasol propionate—Pain—Capecitabine—kidney cancer	0.000188	0.00125	CcSEcCtD
Clobetasol propionate—NR3C1—Circadian Clock—HIF1A—kidney cancer	0.000185	0.00632	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—ACY1—kidney cancer	0.000185	0.0063	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000182	0.0062	CbGpPWpGaD
Clobetasol propionate—Alopecia—Doxorubicin—kidney cancer	0.000176	0.00117	CcSEcCtD
Clobetasol propionate—Methylprednisolone—ABCB1—kidney cancer	0.000174	0.0405	CrCbGaD
Clobetasol propionate—Erythema—Doxorubicin—kidney cancer	0.000173	0.00115	CcSEcCtD
Clobetasol propionate—Triamcinolone—PTGS2—kidney cancer	0.000172	0.0401	CrCbGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.00017	0.0058	CbGpPWpGaD
Clobetasol propionate—Rash—Paclitaxel—kidney cancer	0.000169	0.00112	CcSEcCtD
Clobetasol propionate—Dermatitis—Paclitaxel—kidney cancer	0.000168	0.00112	CcSEcCtD
Clobetasol propionate—Headache—Paclitaxel—kidney cancer	0.000167	0.00111	CcSEcCtD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000165	0.00561	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Capecitabine—kidney cancer	0.000162	0.00107	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—ALDH1A1—kidney cancer	0.000159	0.00541	CbGpPWpGaD
Clobetasol propionate—Pruritus—Capecitabine—kidney cancer	0.000155	0.00103	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	0.000153	0.00521	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000153	0.0052	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—JUN—kidney cancer	0.000152	0.00518	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.00015	0.0051	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000149	0.00509	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000146	0.000974	CcSEcCtD
Clobetasol propionate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000143	0.00487	CbGpPWpGaD
Clobetasol propionate—Betamethasone—PTGS2—kidney cancer	0.000141	0.0329	CrCbGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000141	0.0048	CbGpPWpGaD
Clobetasol propionate—Infection—Doxorubicin—kidney cancer	0.00014	0.000934	CcSEcCtD
Clobetasol propionate—Rash—Capecitabine—kidney cancer	0.000138	0.000919	CcSEcCtD
Clobetasol propionate—Dermatitis—Capecitabine—kidney cancer	0.000138	0.000918	CcSEcCtD
Clobetasol propionate—NR3C1—Endoderm Differentiation—APC—kidney cancer	0.000138	0.0047	CbGpPWpGaD
Clobetasol propionate—Headache—Capecitabine—kidney cancer	0.000137	0.000913	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—kidney cancer	0.000137	0.000913	CcSEcCtD
Clobetasol propionate—Prednisone—ABCB1—kidney cancer	0.000133	0.0309	CrCbGaD
Clobetasol propionate—Dexamethasone—CYP1A1—kidney cancer	0.000131	0.0306	CrCbGaD
Clobetasol propionate—Paraesthesia—Doxorubicin—kidney cancer	0.000127	0.000844	CcSEcCtD
Clobetasol propionate—Prednisolone—ABCB1—kidney cancer	0.000123	0.0285	CrCbGaD
Clobetasol propionate—Pain—Doxorubicin—kidney cancer	0.000121	0.000804	CcSEcCtD
Clobetasol propionate—Betamethasone—ABCB1—kidney cancer	0.00012	0.0279	CrCbGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000116	0.00394	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000115	0.00392	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	0.000113	0.00385	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	0.000109	0.00373	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—kidney cancer	0.000106	0.00362	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000105	0.00358	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Doxorubicin—kidney cancer	0.000104	0.000692	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.000103	0.00352	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Tryptophan metabolism—CYP1A1—kidney cancer	0.000103	0.00352	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	0.000103	0.00352	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	0.000102	0.00347	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	0.000101	0.00345	CbGpPWpGaD
Clobetasol propionate—Pruritus—Doxorubicin—kidney cancer	0.0001	0.000665	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	9.95e-05	0.00339	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—RELA—kidney cancer	9.9e-05	0.00337	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.75e-05	0.00332	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	9.68e-05	0.0033	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	9.65e-05	0.00329	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	9.62e-05	0.00328	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	9.48e-05	0.00323	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—HARS—kidney cancer	9.47e-05	0.00323	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	9.36e-05	0.00319	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTT1—kidney cancer	9.33e-05	0.00318	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—HIF1A—kidney cancer	9.31e-05	0.00317	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	9.27e-05	0.00316	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	9.24e-05	0.00315	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	9.22e-05	0.00314	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	9.15e-05	0.00312	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	9.11e-05	0.00311	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	9.11e-05	0.00311	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—PTGS2—kidney cancer	9e-05	0.00307	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	8.92e-05	0.00304	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	8.92e-05	0.00304	CbGpPWpGaD
Clobetasol propionate—Rash—Doxorubicin—kidney cancer	8.91e-05	0.000593	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—kidney cancer	8.91e-05	0.000592	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—kidney cancer	8.86e-05	0.000589	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—PTGS1—kidney cancer	8.74e-05	0.00298	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	8.68e-05	0.00296	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	8.35e-05	0.00285	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	8.34e-05	0.00284	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.23e-05	0.00281	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—PTGS2—kidney cancer	8.22e-05	0.0191	CrCbGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	8.2e-05	0.0028	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	8.12e-05	0.00277	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—EIF5B—kidney cancer	8.06e-05	0.00275	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	8.05e-05	0.00274	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.91e-05	0.00269	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.71e-05	0.00263	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	7.58e-05	0.00258	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	7.41e-05	0.00253	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	7.05e-05	0.0024	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—ABCB1—kidney cancer	6.99e-05	0.0163	CrCbGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—kidney cancer	6.97e-05	0.00238	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	6.82e-05	0.00232	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.76e-05	0.0023	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	6.71e-05	0.00229	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	6.59e-05	0.00225	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	6.48e-05	0.00221	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTP1—kidney cancer	6.47e-05	0.0022	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	6.44e-05	0.0022	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	6.39e-05	0.00218	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTP1—kidney cancer	6.38e-05	0.00217	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	6.34e-05	0.00216	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	6.31e-05	0.00215	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.22e-05	0.00212	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	6.13e-05	0.00209	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	6.08e-05	0.00207	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTT1—kidney cancer	5.95e-05	0.00203	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTM1—kidney cancer	5.94e-05	0.00203	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTM1—kidney cancer	5.86e-05	0.002	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	5.81e-05	0.00198	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	5.81e-05	0.00198	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	5.74e-05	0.00196	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	5.69e-05	0.00194	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—CTNNB1—kidney cancer	5.57e-05	0.0019	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—PTGS1—kidney cancer	5.57e-05	0.0019	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	5.53e-05	0.00189	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	5.36e-05	0.00183	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	5.23e-05	0.00178	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—EEF2—kidney cancer	5.19e-05	0.00177	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.04e-05	0.00172	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—TET2—kidney cancer	4.98e-05	0.0017	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ACY1—kidney cancer	4.95e-05	0.00169	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.92e-05	0.00168	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	4.86e-05	0.00165	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	4.83e-05	0.00165	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	4.82e-05	0.00164	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—TCEB1—kidney cancer	4.55e-05	0.00155	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—TCEB2—kidney cancer	4.55e-05	0.00155	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	4.45e-05	0.00152	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	4.35e-05	0.00148	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	4.25e-05	0.00145	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	4.24e-05	0.00145	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.23e-05	0.00144	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PDHB—kidney cancer	4.21e-05	0.00144	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—POMC—kidney cancer	4.2e-05	0.00143	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTP1—kidney cancer	4.12e-05	0.00141	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	4.11e-05	0.0014	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	4.07e-05	0.00139	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CCBL1—kidney cancer	3.96e-05	0.00135	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTM1—kidney cancer	3.79e-05	0.00129	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	3.74e-05	0.00127	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—RPL14—kidney cancer	3.7e-05	0.00126	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	3.59e-05	0.00122	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.58e-05	0.00122	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	3.54e-05	0.00121	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPAT—kidney cancer	3.43e-05	0.00117	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GLIPR1—kidney cancer	3.43e-05	0.00117	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.39e-05	0.00116	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.36e-05	0.00114	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—APRT—kidney cancer	3.19e-05	0.00109	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—FH—kidney cancer	3.19e-05	0.00109	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ACY1—kidney cancer	3.16e-05	0.00108	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.12e-05	0.00106	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—HSPB1—kidney cancer	3.02e-05	0.00103	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	3.02e-05	0.00103	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GPC3—kidney cancer	3e-05	0.00102	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CA2—kidney cancer	2.92e-05	0.000995	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALAD—kidney cancer	2.85e-05	0.00097	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PSMD7—kidney cancer	2.8e-05	0.000955	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ST3GAL2—kidney cancer	2.78e-05	0.000947	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALDH1A1—kidney cancer	2.71e-05	0.000925	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.69e-05	0.000918	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PDHB—kidney cancer	2.69e-05	0.000916	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—POMC—kidney cancer	2.68e-05	0.000913	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SLC5A3—kidney cancer	2.6e-05	0.000887	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PGK1—kidney cancer	2.6e-05	0.000887	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—LDHB—kidney cancer	2.55e-05	0.00087	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CCBL1—kidney cancer	2.53e-05	0.000861	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—JUNB—kidney cancer	2.52e-05	0.000858	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.28e-05	0.000778	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CA9—kidney cancer	2.21e-05	0.000754	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPAT—kidney cancer	2.19e-05	0.000746	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.19e-05	0.000746	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.16e-05	0.000737	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.14e-05	0.000729	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—CDKN2B—kidney cancer	2.05e-05	0.000698	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—FH—kidney cancer	2.04e-05	0.000694	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—APRT—kidney cancer	2.04e-05	0.000694	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.99e-05	0.000678	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GPC3—kidney cancer	1.91e-05	0.000652	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CRABP1—kidney cancer	1.88e-05	0.000641	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CA2—kidney cancer	1.86e-05	0.000635	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALAD—kidney cancer	1.81e-05	0.000618	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.77e-05	0.000604	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ITPR2—kidney cancer	1.75e-05	0.000596	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.73e-05	0.00059	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.66e-05	0.000566	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PGK1—kidney cancer	1.66e-05	0.000566	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.65e-05	0.000562	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—LDHB—kidney cancer	1.63e-05	0.000555	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.61e-05	0.00055	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ACHE—kidney cancer	1.6e-05	0.000544	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTT1—kidney cancer	1.6e-05	0.000544	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SCARB1—kidney cancer	1.51e-05	0.000515	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTGS1—kidney cancer	1.49e-05	0.000509	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PSMD7—kidney cancer	1.47e-05	0.0005	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CA9—kidney cancer	1.41e-05	0.000481	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—BCHE—kidney cancer	1.39e-05	0.000474	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.38e-05	0.00047	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SLC5A5—kidney cancer	1.37e-05	0.000468	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SLC2A1—kidney cancer	1.33e-05	0.000452	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.29e-05	0.000438	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CRABP1—kidney cancer	1.2e-05	0.000409	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.12e-05	0.000382	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ITPR2—kidney cancer	1.12e-05	0.00038	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTP1—kidney cancer	1.11e-05	0.000377	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ABCB1—kidney cancer	1.05e-05	0.000357	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.03e-05	0.00035	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ACHE—kidney cancer	1.02e-05	0.000347	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTT1—kidney cancer	1.02e-05	0.000347	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTM1—kidney cancer	1.02e-05	0.000346	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SCARB1—kidney cancer	9.63e-06	0.000328	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTGS1—kidney cancer	9.53e-06	0.000325	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PSMD7—kidney cancer	9.35e-06	0.000319	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—BCHE—kidney cancer	8.86e-06	0.000302	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SLC5A5—kidney cancer	8.75e-06	0.000298	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SLC2A1—kidney cancer	8.45e-06	0.000288	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.2e-06	0.00028	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MAPK3—kidney cancer	8.16e-06	0.000278	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MYC—kidney cancer	7.94e-06	0.000271	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.91e-06	0.00027	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—POMC—kidney cancer	7.18e-06	0.000245	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.15e-06	0.000244	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTP1—kidney cancer	7.05e-06	0.00024	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ABCB1—kidney cancer	6.67e-06	0.000227	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTM1—kidney cancer	6.48e-06	0.000221	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.14e-06	0.000209	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTGS2—kidney cancer	5.73e-06	0.000195	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.05e-06	0.000172	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTEN—kidney cancer	5e-06	0.00017	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—POMC—kidney cancer	4.58e-06	0.000156	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTGS2—kidney cancer	3.65e-06	0.000124	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CA—kidney cancer	3.52e-06	0.00012	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTEN—kidney cancer	3.19e-06	0.000109	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.25e-06	7.66e-05	CbGpPWpGaD
